Search

everythinglearnresearchcommunity

for

Search:↓

Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.

The treatment was effective for advanced non-Hodgkin's lymphomas.

4-O-methylhonokiol from Magnolia Officinalis may promote hair growth by interfering with TGF-β1 effects in skin cells.

The model successfully predicted new uses for existing drugs, like using certain hormonal and heart medications for respiratory and Parkinson's diseases, and a cancer drug for diabetes.

Minoxidil analogs can be improved for hair growth inhibition by modifying specific parts of their structure.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

Scopolin and scopoletin from Merremia peltata leaves may help treat hair loss and showed promising results in rabbit tests.

Clinical trials should use innovative designs and biomarkers to improve precision therapy and patient outcomes.

Pembrolizumab can cause unusual eyelash growth, but it may still be worth continuing if cancer treatment is effective.

Retinoids can help treat skin pigmentation disorders by affecting melanin production.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Topical clobetasol is recommended over mycophenolate mofetil for treating Lichen Planopilaris due to better safety and patient satisfaction.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Mycophenolate mofetil effectively improved skin pigmentation and itching in a woman with lichen planus pigmentosus and frontal fibrosing alopecia.

FOL-026 peptide can help repair blood vessels and promote growth, offering potential treatment for vascular diseases.

Sorafenib often causes mucositis, hand-foot syndrome, rash, alopecia, diarrhea, and fatigue.

Low-dose oral and sublingual minoxidil seem safe for children with hair disorders.

Minoxidil protects heart and improves recovery.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Moracin M helps hair grow by activating specific pathways and improving blood vessel formation.

A rare skin reaction from cancer treatment was successfully managed with topical treatments and antihistamines.

Patient had scalp allergy from minoxidil; test helped identify cause and suggest alternative treatments.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Hedgehog pathway inhibitors used for skin cancer can cause significant hair loss, which may improve after stopping the medication.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

No method fully prevents hair loss from chemotherapy, but some methods can reduce it and improve quality of life.